We evaluated FKS1 and FKS2 mutations in Candida parapsilosis bloodstream isolates and correlated them with the echinocandin MIC values determined by guidelines in CLSI document M27-A3 and the YeastOne panel. All mutations detected were outside hot spot (HS) regions. The F1386S mutation detected in an isolate that was resistant by the YeastOne panel but not by the M27-A3 guidelines might be implicated in echinocandin resistance. Further studies are needed to confirm the implication of the F1386S mutation and to elucidate the capability of the M27-A3 guidelines to detect echinocandin resistance.
T
he Fksp subunits of the ␤-1,3-D-glucan synthase enzyme are the target of echinocandins (1) and are encoded by the FKS1, FKS2, and FKS3 genes. The acquired reduced echinocandin susceptibility (RES) in most of the strains of Candida spp. involves high echinocandin MICs and amino acid substitutions in two hot spot (HS) regions of the FKS1 and FKS2 genes (2) (3) (4) (5) (6) (7) (8) (9) .
The mechanism leading to acquired RES in Candida parapsilosis isolates has not yet been described, since no clinical isolates with acquired echinocandin resistance have revealed mutations in either the HS1 or HS2 region of the FKS1 gene (10-13). The only mutation described to date in the HS regions is a naturally occurring proline-to-alanine substitution in the HS1 region of the FKS1 gene. This polymorphism is responsible for the intrinsic RES of C. parapsilosis to echinocandins (14) . Regarding the FKS2 gene, mutations in the HS regions have not yet been analyzed.
Our aim was to analyze resistance to echinocandins in 77 bloodstream C. parapsilosis sensu stricto isolates by correlating acquired FKS gene alterations with the MICs of caspofungin (CFG), micafungin (MFG), and anidulafungin (AFG) determined by the CLSI M27-A3 document guidelines (15) and by the Sensititre YeastOne SYO-10 panel (Trek Diagnostic Systems, England). The MICs were read after 24 h of incubation, and the interpretive criteria used were those published in CLSI document M27-S4 (16). Molecular identification was performed by sequencing the internal transcribed spacer 1 (ITS1) and ITS2 regions (17) . Genomic DNA was extracted using the commercial method InstaGene matrix (Bio-Rad). The fragments that included the HS1 (amino acids 537 to 793) and HS2 (amino acids 1277 to 1488) regions of the FKS1 gene were characterized in all C. parapsilosis isolates using the Candida FKS universal primers (14) . The fragments that included the HS1 (amino acids 476 to 669) and HS2 (amino acids 1114 to 1316) regions of the FKS2 gene were analyzed in a subset of 21 isolates (6 resistant isolates, 9 susceptible isolates with an FKS1 mutation, and 6 other susceptible isolates, all of them determined by the YeastOne panel) using primers designed for this study: CpF2H1F (5=-CCAACCGCAAATACTTACC-3=), CpF2H1R (5=-AATGATGCCTCCTTCTTGAC-3=), CpF2H2F (5=-TATGCAATGCGGTAAAGGAC-3=), and CpF2H2R (5=-C TCCACGGCAAATCTTGAG-3=). The DNA sequences were compared to C. parapsilosis reference sequences (GenBank accession no. EU221325 and EU221326 for the FKS1 and FKS2 genes, respectively) (14) .
Employing the YeastOne panel, six of the 77 C. parapsilosis isolates were resistant to at least one echinocandin; employing the M27-A3 guidelines, the isolates were susceptible to the three echinocandins ( Table 1 ). The essential agreement (EA) between the methods for the three echinocandins was 98.7%, which is lower than that reported in other studies in which no resistant C. parapsilosis isolates were included (18, 19) . The categorical agreements (CA) were 92.3%, 94.8%, and 98.7% for AFG, MFG, and CFG, respectively. CFG is the agent with the highest CA, despite in vitro susceptibility testing of CFG currently not being recommended due to reproducibility problems (20, 21) . The majority of the errors were observed in the isolates classified as susceptible by the M27-A3 guidelines and intermediate to AFG (minor error, 6.2%), MFG (minor error, 3.9%), or CFG (minor error, 1.3%) by the YeastOne panel. Major errors were observed with AFG (1.5%) and MFG (1.3%); in each case, there was one isolate that was resistant according to the YeastOne panel and susceptible according to the M27-A3 guidelines. Since it seems that there is no concordance between the YeastOne panel and the M27-A3 guidelines for detecting resistant isolates, more studies are necessary to elucidate which method best classifies the isolates that harbor resistance mechanisms.
All C. parapsilosis isolates analyzed in this study harbored the previously described (14) naturally occurring polymorphism P660A in the HS1 region of the FKS1 gene. However, despite our observing an appreciable range of echinocandin MIC values by the YeastOne panel, none of the 77 C. parapsilosis isolates harbored mutations in either the HS1 (652 to 660) or HS2 (1369 to 1376) region of Fks1p apart from the naturally occurring polymorphism.
Sequence alignments showed that 11 of the 77 (14.3%) C. parapsilosis isolates harbored mutations outside the two HS regions of the FKS1 gene, which have not been described. Six of the 11 mutations were detected in a single allele (heterozygous), and the remaining 5 were detected in both alleles (homozygous). The mutations were V595I (1 isolate), S745L (6 isolates that subsequently showed a clonal relationship), M1328I (2 isolates), F1386S (1 isolate), and A1422G (1 isolate) ( Table 1 ). The S745L, M1328I, and A1422G mutations were identified in nine echinocandin-susceptible isolates, suggesting that these mutations are not implicated in susceptibility to echinocandins. On the other hand, the V595I and F1386S mutations were identified exclusively in isolates that were determined by the YeastOne panel to be echinocandin resistant (Table 1 ). The homozygous mutation V595I was identified in the only strain that was intermediate to caspofungin (MIC, 4 g/ml), but this mutation is a conservative substitution. However, the heterozygous mutation F1386S was identified in a strain that was resistant to AFG (MIC, 8 g/ml) and intermediate to MFG (MIC, 4 g/ml). This mutation was nonconservative, and interestingly, we found that it was situated 10 amino acids beyond the HS2 region (amino acids 1369 to 1376).
As seen in Table 2 , the phenylalanine residue was highly conserved in the 7 Candida species and in the yeast Saccharomyces cerevisiae, and the valine residue, situated at the 595 position, was conserved in the 7 Candida species. This high homology (74%) observed between S. cerevisiae and the C. parapsilosis ␤-1,3-D- 
The MIC interpretive criteria used were those published in the CLSI document M27-S4 (16) glucan synthase enzymes led us to extrapolate the described topology from S. cerevisiae (22) to that for C. parapsilosis, as well as to consider that the V595I mutation is located in a transmembrane domain and the mutation F1386S is located externally and close to the HS2 region. We found that none of the 21 C. parapsilosis isolates that were screened for FKS2 gene alterations presented mutations in the HS1 and HS2 regions, which suggests a lack of involvement of this gene in the susceptibility to echinocandins in C. parapsilosis.
Our findings highlight the lack of a correlation between the YeastOne panel and M27-A3 guidelines for detecting echinocandin-resistant C. parapsilosis clinical isolates. Moreover, our findings highlight the absence of mutations in the HS regions of the FKS1 and FKS2 genes in those isolates resistant to echinocandins as determined by the YeastOne panel. This suggests that other regions of these genes may harbor mutations, such as the F1386S or V595I mutation, which we found outside HS regions, as was also recently described in S. cerevisiae (23) . However, these results should be confirmed by genetic engineering or by determining the 50% inhibitory concentrations for the mutant enzymes, because other mechanisms, such as a compensatory increase in the production of chitin, may also play an important role in decreasing the efficacy of echinocandins both in vitro and in vivo (24) (25) (26) .
